Urolithin A
Urolithin A (Mitopure) · also known as Urolithin A, UA, Mitopure, Pomegranate ellagic acid gut metabolite
Urolithin A is a metabolite that gut bacteria make from pomegranate ellagitannins. Human randomized trials have observed changes in some muscle and mitochondrial markers, but improvements in autophagic flux, muscle strength and mitochondrial respiratory efficiency have not been consistently confirmed.
Clinical uses and human evidence
Muscle strength and mass
Studies (2)
- Dao 2026 · Front Nutr · Meta-analysis · n=236 — Effects of Urolithin A supplementation on muscle health outcomes in humans from randomized controlled trials
- Singh 2022 · Cell Rep Med · RCT · n=88 — Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults
Endurance performance
Studies (2)
- Dao 2026 · Front Nutr · Meta-analysis · n=236 — Effects of Urolithin A supplementation on muscle health outcomes in humans from randomized controlled trials
- Liu 2022 · JAMA Netw Open · RCT · n=66 — Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial
Mechanisms of action
Selective induction of mitophagy (PINK1-Parkin)
Urolithin A can modulate markers of the PINK1/Parkin pathway in muscle. In one human randomized trial, phosphorylated Parkin rose in muscle biopsies from the 500 mg/day group, and the analysis was mainly a within-group before-and-after comparison. Autophagic flux and clinical effects remain undetermined.
Inhibition of NF-κB / AP-1, the master switches of pro-inflammatory transcription
In a sleep-deprivation mouse model, urolithin A reduced NF-κB- and NLRP3-related signaling in the hippocampus. Changes in human inflammatory markers cannot by themselves prove NF-κB inhibition. The cGAS–STING and NLRP3 pathways are also not the same thing as NF-κB, and human evidence is still insufficient.